LGALS1 and idiopathic pulmonary fibrosis: IPF patients suffer from gradual decline in lung function, which worsens during phases of AE associated with hypoxemia.8,32 Based on above results, we hypothesized that hypoxia could be a major contributor in lung function decline, which can be rescued by galectin-1 inhibition.